Determinants of central sympathetic activation in spontaneous primary subarachnoid hemorrhage

Neurocritical Care

Volumn 16, Issue 3, 2012, Pages 381-388

  Moussouttas, Michael ^a   Lai, Edwin W ^b   Khoury, John ^a   Huynh, Thanh T ^b   Dombrowski, Keith ^a   Pacak, Karel ^b  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Catecholamines; Cerebrospinal fluid; Subarachnoid hemorrhage; Sympathetic nervous system

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 3,4 DIHYDROXYPHENYLETHYLENE GLYCOL; ADRENALIN; DOPA; DOPAMINE; NORADRENALIN; 4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; DRUG DERIVATIVE;

ADULT; AGE; AGED; ANTERIOR CEREBRAL ARTERY; ANTERIOR CEREBRAL ARTERY ANEURYSM; ANTERIOR COMMUNICATING ARTERY ANEURYSM; ARTICLE; BRAIN ARTERY ANEURYSM; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; FEMALE; HUMAN; HUNT HESS GRADE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; SCORING SYSTEM; SEX DIFFERENCE; SUBARACHNOID HEMORRHAGE; SYMPATHETIC FUNCTION; ADRENERGIC SYSTEM; CEREBROSPINAL FLUID; CRITICAL ILLNESS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX;

3,4-DIHYDROXYPHENYLACETIC ACID; ADULT; AGED; AGED, 80 AND OVER; CRITICAL ILLNESS; DIHYDROXYPHENYLALANINE; EPINEPHRINE; FEMALE; HUMANS; MALE; METHOXYHYDROXYPHENYLGLYCOL; MIDDLE AGED; NOREPINEPHRINE; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SUBARACHNOID HEMORRHAGE; SYMPATHETIC NERVOUS SYSTEM;

EID: 84873031941     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-012-9673-5     Document Type: Article

References (33)

1. Naredi S, Lambert G, Eden E, Zall S, Runnerstam M, Rydenhag B, Friberg P. Increased sympathetic nervous activity in patients with nontraumatic subarachnoid hemorrhage. Stroke. 2000;31:901-6.
2. Lee V, Oh J, Mulvagh S, Wijdicks E. Mechanisms in neurogenic stress cardiomyopathy after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2006;5:243-9.
3. Bruder N, Rabinstein A. Cardiovascular and pulmonary complications of aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2011;15:257-69.
4. Khush K, Kopelnik A, Tung P, et al. Age and aneurysm position predict patterns of left ventricular dysfunction after subarachnoid hemorrhage. J Am Soc Echo. 2005;18:168-74.
5. Tung P, Kopelnik A, Banki N, et al. Predictors of neurocardiogenic injury after subarachnoid hemorrhage. Stroke. 2004;35: 548-53.
6. Eisenhofer G, Goldstein D, Stull R, Keiser H, Sunderland T, Murphy D, Kopin I. Simultaneous liquid chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem. 1986;32:2030-3.
7. Kramer A, Hehir M, Nathan B, Gress D, Dumont A, Kassell N, Bleck T. A comparison of 3 radiographic scales for the prediction of delayed ischemia and prognosis following subarachnoid hemorrhage. J Neurosurg. 2008;109:199-207.
8. Vinken P, Bruyn G, editors. The autonomic nervous system. Amsterdam: Elsevier; 1999.
9. Feenstra M. Dopamine and noradrenaline release in the prefrontal cortex in relation to unconditioned and conditioned stress and reward. Prog Brain Res. 2000;126:133-63.
10. Raskind M, Peskind E, Holmes C, Goldstein D. Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and alzheimer's disease. Biol Psychiatry. 1999;46:756-65.
11. Ebinger G. The significance of homovanillic acid and 3,4- dihydroxyphenylacetic acid concentrations in human lumbar cerebrospinal fluid. J Neurochem. 1987;48:1725-9.
12. Lenders J, Willemsen J, Beissel T, Kloppenborg P, Thien T, Benraad T. Value of the plasma norepinephrine/3,4-dihydroxyphenylglycol ratio for the diagnosis of pheochromocytoma. Am J Med. 1992;92:147-52.
13. Mayer S, Lin J, Homma S, et al. Myocardial injury and left ventricular performance after subarachnoid hemorrhage. Stroke. 1999;30:780-6.
14. Kothavale A, Banki N, Kopelnik A, et al. Predictors of left ventricular regional wall motion abnormalities after subarachnoid hemorrhage. Neurocrit Care. 2006;4:199-205.
15. Wittstein I, Thiemann D, Lima J, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005;352:539-48.
16. Kopelnik A, Fisher L, Miss J, et al. Prevalence and implications of diastolic dysfunction after subarachnoid hemorrhage. Neurocrit Care. 2005;3:132-8.
17. Zaroff J, Pawlikowska L, Miss J, et al. Adrenoceptor polymorphisms and the risk of cardiac injury and dysfunction after subarachnoid hemorrhage. Stroke. 2006;37:1680-5.
18. Lambert G, Naredi S, Eden E, Rydenhag B, Friberg P. Monoamine metabolism and sympathetic nervous system activation following subarachnoid hemorrhage - influence of gender and hydrocephalus. Brain Res Bull. 2002;58:77-82.
19. Shivalkar B, Van Loon J, Wieland W, Tjandra-Maga T, Borgers M, Plets C, Flameng W. Variable effects of explosive or gradual increase of intracranial pressure on myocardial structure and function. Circulation. 1993;87:230-9.
20. Marion D, Segal R, Thompson M. Subarachnoid hemorrhage and the heart. Neurosurgery. 1986;18:101-6.
21. Stoddard-Apter S, Siegel A, Levin B. Plasma catecholamine and cardiovascular responses following hypothalamic stimulation in the awake cat. J Auton Nerv Syst. 1983;8:343-60.
22. Saito M, Moinokoshi Y, Shimazu T. Accelerated norephinephrine turnover in peripheral tissues after ventromedial hypothalamic stimulation in rats. Brain Res. 1989;481:298-303.
23. Melville K, Blum B, Shister H, Silver M. Cardiac ischemic changes and arrhythmias induced by hypothalamic stimulation. Am J Cardiol. 1963;12:781-91.
24. Neil-Dwyer G, Walter P, Cruickshank J, Doshi R, O'Gorman P. Effect of propranolol and phentolamine on myocardial necrosis after subarachnoid hemorrhage. BMJ. 1978;2:990-2.
25. Masuda T, Sato K, Yamamoto S, et al. Sympathetic nervous activity and myocardial damage immediately after subarachnoid hemorrhage in a unique animal model. Stroke. 2002;33:1671-6.
26. Doshi R, Neil-Dwyer G. Hypothalamic and myocardial lesions after subarachnoid hemorrhage. J Neurol Neurosurg Psychiatry. 1977;40:821-6.
27. Meyer S, Strittmatter M, Fischer C, Georg T, Schmitz B. Lateralization in autonomic dysfunction in ischemic stroke involving the insular cortex. Neuroreport. 2004;15:357-61.
28. Sykora M, Diedler J, Rupp A, Turcani P, Steiner T. Impaired baroreceptor reflex sensitivity in acute stroke is associated with insular involvement but not with carotid atherosclerosis. Stroke. 2009;40:737-42.
29. Butcher K, Cechetto D. Insular lesion invokes autonomic effects of stroke in normotensive and hypertensive rats. Stroke. 1995;26:459-65.
30. Fiorella D, Albuquerque F, Han P, McDougall C. Preliminary experience using the neuroform stent for the treatment of cerebral aneurysms. Neurosurgery. 2004;54:6-16.
31. Jayaraman M, Huy M, Versnick E, Seteinberg G, Marks M. Morphologic assessment of middle cerebral artery aneurysms for endovascular treatment. J Stroke Cerebrovasc Dis. 2007;16:52-6.
32. Fink J, Selim M, Kumar S, Voetsch B, Fong W, Caplan L. Insular cortex infarction in acute middle cerebral artery stroke - predictor of stroke severity and vascular lesion. Arch Neurol. 2005;62: 1081-5.
33. Moussouttas M, Lai E, Dombrowski K, Huynh T, Khoury J, Carmona G, DeCaro M, Pacak K. CSF catecholamine profile in subarachnoid hemorrhage patients with neurogenic cardiomyopathy. Neurocrit Care. 2011;14:401-6.